tiprankstipranks
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H (HK:2185)
:2185
Hong Kong Market

Compare Shanghai Bio-Heart Biological Technology Co., Ltd. Class H (2185) vs. Competitors

0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H
HK$5.71
HK$1.07B
-18.55
119.00%
Genor Biopharma Holdings Limited
HK$3.06
HK$6.04B
2.00
52.02%
TOT BIOPHARM International Co. Ltd.
HK$2.50
HK$3.76B
-16.66
185.88%
Zhaoke Ophthalmology Ltd.
HK$3.17
HK$1.64B
-7.14
104.11%
Immunotech Biopharm Ltd
HK$2.68
HK$2.16B
-6.43
4.32%
Hightide Therapeutics Inc
HK$3.05
HK$1.82B
-5.33
169.17%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2185
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H
4.38
2.23
103.72%
HK:6998
Genor Biopharma Holdings Limited
3.01
0.90
42.65%
HK:1875
TOT BIOPHARM International Co. Ltd.
4.86
3.23
198.16%
HK:6622
Zhaoke Ophthalmology Ltd.
2.98
1.42
91.03%
HK:6978
Immunotech Biopharm Ltd
3.50
-0.24
-6.42%
HK:2511
Hightide Therapeutics Inc
3.58
2.08
138.67%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts